Description
Endoxifen is the metabolite of Tamoxifen (Cat. No.1551) and Estrogen receptor α (ERα) ligand. Endoxifen is responsible for the effectiveness of tamoxifen in ER-positive breast cancer. Potent antiestrogen.
Endoxifen is the metabolite of Tamoxifen (Cat. No.1551) and Estrogen receptor α (ERα) ligand. Endoxifen is responsible for the effectiveness of tamoxifen in ER-positive breast cancer. Potent antiestrogen.
Alternate Name/Synonyms: (E/Z)-4-[1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol
Appearance: White solid
Formulation: N/A
CAS Number: 112093-28-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₅H₂₇NO₂
Molecular Weight: 373.49
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>30 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: Endoxifen is the metabolite of Tamoxifen and an Estrogen receptor α (ERα) ligand.
MDL Number: N/A
PubChem CID: 10090750
SMILES: CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3
InChi: InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24-
InChi Key: MHJBZVSGOZTKRH-IZHYLOQSSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |